Agranulocytosis
  Identification and selection for case-control analysis of patients with agranulocytosis (until June 30, 2001).
Versión PDF
  Yearly incidence of agranulocytosis in the study area.
Versión PDF
  Drugs exposures between 9 and 3 days before the index day, and ≥3 days within the week before the index day.
Versión PDF
  Use of drugs included into the analysis according to the diagnostic categories in control patients.
Versión PDF
  Use of drugs by group according to diagnostic category in control patients.
Versión PDF
  Number of cases and controls exposed within the week before the index day to drugs with a moderately high prevalence of use.
Versión PDF


Persona de contacte - Lluisa Ibañez